Biktarvy, formally known as biktarvy, represents a potent single-tablet regimen for treating HIV infection. This formula unites three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the virus's ability to multiply within the body, significantly decreasing the viral load. For many indi